ACORN CAPITAL ADVISORS, LLC Long-Term Concentrated

CIK: 0002054410 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 17, 2025

Total Value ($000): $196,994 (100.0% shares, 0.0% debt)

Holdings (20)

CGON CG ONCOLOGY INC 23.1%

Value ($000) $45,577 Shares 1,131,501 Est. Cost $34.21 Unrealized -15.0%

URGN UROGEN PHARMA LTD 12.8%

Value ($000) $25,132 Shares 1,259,749 Est. Cost $11.97 Unrealized +50.0%

PBYI PUMA BIOTECHNOLOGY INC 11.1%

Value ($000) $21,937 Shares 4,131,299 Est. Cost $2.92 Unrealized +45.1%

TRVI TREVI THERAPEUTICS INC 10.0%

Value ($000) $19,625 Shares 2,144,844 Est. Cost $3.31 Unrealized +126.8%

TERN TERNS PHARMACEUTICALS INC 7.5%

Value ($000) $14,804 Shares 1,971,264 Est. Cost $6.77 Unrealized -5.7%

CADL CANDEL THERAPEUTICS INC 6.7%

Value ($000) $13,161 Shares 2,580,517 Est. Cost $5.97 Unrealized -3.2%

BCAX BICARA THERAPEUTICS 5.2%

Value ($000) $10,159 Shares 643,382 Est. Cost $20.81 Unrealized -46.2%

OKUR ONKURE THERAPEUTICS INC 4.0%

Value ($000) $7,809 Shares 2,839,674 Est. Cost $8.97 Unrealized -72.4%

TARA PROTARA THERAPEUTICS INC 3.9%

Value ($000) $7,622 Shares 1,752,115 Est. Cost $3.29 Unrealized -1.6%

VSTM VERASTEM INC 3.5%

Value ($000) $6,883 Shares 779,498 Est. Cost $3.94 Unrealized +89.0%

HELP CYBIN INC 2.2%

Value ($000) $4,311 Shares 734,394 Est. Cost $10.16 Unrealized -30.2%

CRDF CARDIF ONCOLOGY INC 2.1%

Value ($000) $4,042 Shares 1,962,084 Est. Cost $3.02 Unrealized -8.6%

AURA AURA BIOSCIENCES INC 1.9%

Value ($000) $3,682 Shares 595,744 Est. Cost $7.57 Unrealized -13.6%

BCAB BIOATLA INC 1.7%

Value ($000) $3,336 Shares 4,835,111 Est. Cost $1.47 Unrealized -68.5%

JSPR JASPER THERAPEUTICS 1.7%

Value ($000) $3,291 Shares 1,382,640 Est. Cost $3.03 Unrealized 0.0%

WHWK WHITEHAWK THERAPEUTICS INC 1.1%

Value ($000) $2,165 Shares 1,139,363 Est. Cost $2.27 Unrealized -18.8%

QTTB Q32 BIO INC. 0.8%

Value ($000) $1,591 Shares 803,425 Est. Cost $31.58 Unrealized -93.9%

— X4 PHARMACEUTICALS INC 0.5%

Value ($000) $935 Shares 273,349 Est. Cost $1.91 Unrealized —

ACRV ACRIVON THERAPEUTICS INC 0.4%

Value ($000) $733 Shares 405,237 Est. Cost $7.27 Unrealized -80.7%

VYNE VYNE THERAPEUTICS INC 0.1%

Value ($000) $199 Shares 586,572 Est. Cost $2.55 Unrealized -74.4%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGON	CG ONCOLOGY INC	1,131,501	$45,577	23.1%	$34.21	-15.0%	COM	156944100
URGN	UROGEN PHARMA LTD	1,259,749	$25,132	12.8%	$11.97	+50.0%	COM	M96088105
PBYI	PUMA BIOTECHNOLOGY INC	4,131,299	$21,937	11.1%	$2.92	+45.1%	COM	74587V107
TRVI	TREVI THERAPEUTICS INC	2,144,844	$19,625	10.0%	$3.31	+126.8%	COM	89532M101
TERN	TERNS PHARMACEUTICALS INC	1,971,264	$14,804	7.5%	$6.77	-5.7%	COM	880881107
CADL	CANDEL THERAPEUTICS INC	2,580,517	$13,161	6.7%	$5.97	-3.2%	COM	137404109
BCAX	BICARA THERAPEUTICS	643,382	$10,159	5.2%	$20.81	-46.2%	COM	055477103
OKUR	ONKURE THERAPEUTICS INC	2,839,674	$7,809	4.0%	$8.97	-72.4%	CLASS A COM	68277Q105
TARA	PROTARA THERAPEUTICS INC	1,752,115	$7,622	3.9%	$3.29	-1.6%	COM STK	74365U107
VSTM	VERASTEM INC	779,498	$6,883	3.5%	$3.94	+89.0%	COM	92337C203
HELP	CYBIN INC	734,394	$4,311	2.2%	$10.16	-30.2%	COM NEW	23256X407
CRDF	CARDIF ONCOLOGY INC	1,962,084	$4,042	2.1%	$3.02	-8.6%	COM	14147L108
AURA	AURA BIOSCIENCES INC	595,744	$3,682	1.9%	$7.57	-13.6%	COM	05153U107
BCAB	BIOATLA INC	4,835,111	$3,336	1.7%	$1.47	-68.5%	COM	09077B104
JSPR	JASPER THERAPEUTICS	1,382,640	$3,291	1.7%	$3.03	0.0%	COM	471871202
WHWK	WHITEHAWK THERAPEUTICS INC	1,139,363	$2,165	1.1%	$2.27	-18.8%	COM	00032Q104
QTTB	Q32 BIO INC.	803,425	$1,591	0.8%	$31.58	-93.9%	COM	746964105
—	X4 PHARMACEUTICALS INC	273,349	$935	0.5%	$1.91	—	COM	98420X103
ACRV	ACRIVON THERAPEUTICS INC	405,237	$733	0.4%	$7.27	-80.7%	COMMON STOCK	004890109
VYNE	VYNE THERAPEUTICS INC	586,572	$199	0.1%	$2.55	-74.4%	COM	92941V308